TIME COURSE OF CHANGES IN OPTIC DISK NEOVASCULARIZATION AFTER A SINGLE INTRAVITREAL BEVACIZUMAB INJECTION

被引:9
|
作者
Falavarjani, Khalil Ghasemi [1 ]
Habibi, Abbas [1 ]
Khorasani, Maryam Ashraf [1 ]
Anvari, Pasha [1 ]
Sadda, Srinivas R. [2 ,3 ]
机构
[1] Iran Univ Med Sci, Rassoul Akram Hosp, Dept Ophthalmol, Eye Res Ctr, Tehran, Iran
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Ophthalmol, Los Angeles, CA 90095 USA
[3] Doheny Eye Inst, 1355 San Pablo St, Los Angeles, CA 90033 USA
关键词
bevacizumab; diabetic retinopathy; neovascularization; NVD; optical coherence tomography angiography; PROLIFERATIVE DIABETIC-RETINOPATHY; COHERENCE TOMOGRAPHY-ANGIOGRAPHY; ENDOTHELIAL GROWTH-FACTOR; AVASTIN;
D O I
10.1097/IAE.0000000000002107
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To evaluate the longitudinal changes in optic disk neovascularization (NVD) after intravitreal bevacizumab injection using optical coherence tomography angiography. Methods: In this prospective, interventional, case series, eyes with NVD secondary to diabetic retinopathy were enrolled. En face optical coherence tomography angiographic images were obtained from the optic disks before and 3 hours, 6 hours, 24 hours, 7 days, and 30 days after intravitreal bevacizumab injection. The size and flow area of the neovascularization were measured by two graders. Results: Eleven eyes of 9 patients with a mean age of 52.11 +/- 9.48 years were included. The reduction in the NVD size and flow area was statistically significant at 24 hours, 7 days, and 30 days after injections compared with the baseline measurements (all P < 0.05). The decremental regression in the NVD size and flow area continued during the study course. The changes were not statistically significant in 3-hour and 6-hour measurements (all P > 0.05). Conclusion: In this study, statistically significant regression in the NVD size and flow area was observed as early as 24 hours after a single intravitreal bevacizumab injection, with a continued decreasing trend for at least a 1-month period.
引用
收藏
页码:1149 / 1153
页数:5
相关论文
共 50 条
  • [21] Clinical and histological findings after intravitreal injection of bevacizumab (Avastin®) in a porcine model of choroidal neovascularization
    Lassota, Nathan
    Prause, Jan Ulrik
    Scherfig, Erik
    Kiilgaard, Jens Folke
    la Cour, Morten
    ACTA OPHTHALMOLOGICA, 2010, 88 (03) : 300 - 308
  • [22] Intravitreal bevacizumab (Avastin) injection as primary treatment of inflammatory choroidal neovascularization
    Adan, Alfredo
    Mateo, Carlos
    Navarro, Rafael
    Bitrian, Elena
    Casaroli-Marano, Ricardo P.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2007, 27 (09): : 1180 - 1186
  • [23] RETINAL NEOVASCULARIZATION AFTER INTRAVITREAL FIBROBLAST INJECTION
    TANO, Y
    CHANDLER, DB
    MACHEMER, R
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1981, 92 (01) : 103 - 109
  • [24] Choroidal neovascularization treated with intravitreal injection of bevacizumab (Avastin) in angioid streaks
    Teixeira, Anderson
    Moraes, Nilva
    Farah, Michel Eid
    Bonomo, Pedro Paulo
    ACTA OPHTHALMOLOGICA SCANDINAVICA, 2006, 84 (06): : 835 - 836
  • [25] Intravitreal Injection of Bevacizumab for the Treatment of Choroidal Neovascularization in a Patient with Angioid Streaks
    Liu, Yu-Chi
    Yang, Chang-Sue
    Shyong, Meng-Ping
    Lee, Fenq-Lih
    Lee, Shui-Mei
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2009, 72 (02) : 98 - 102
  • [26] CHANGES OF CHOROIDAL NEOVASCULARIZATION IN INDOCYANINE GREEN ANGIOGRAPHY AFTER INTRAVITREAL RANIBIZUMAB INJECTION
    Lee, Ji Eun
    Kim, Hyun Woong
    Lee, Sang Joon
    Lee, Joo Eun
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (05): : 999 - 1006
  • [27] Reflux after intravitreal injection of bevacizumab - Reply
    Benz, Matthew S.
    OPHTHALMOLOGY, 2008, 115 (07) : 1269 - 1269
  • [28] Subjective sensations after intravitreal injection of bevacizumab
    Ach, T.
    Dawczynski, J.
    Koenigsdoerffer, E.
    Augsten, R.
    Strobel, J.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2007, 224 (03) : 180 - 184
  • [29] Complications in patients after intravitreal injection of bevacizumab
    Shima, Chiharu
    Sakaguchi, Hirokazu
    Gomi, Fumi
    Kamei, Motohiro
    Ikuno, Yasushi
    Oshima, Yusuke
    Sawa, Miki
    Tsujikawa, Motokazu
    Kusaka, Shunji
    Tano, Yasuo
    ACTA OPHTHALMOLOGICA, 2008, 86 (04) : 372 - 376
  • [30] Long-term intraocular pressure changes after intravitreal injection of bevacizumab
    Baek, Sung Uk
    Park, In Won
    Suh, Wool
    CUTANEOUS AND OCULAR TOXICOLOGY, 2016, 35 (04) : 310 - 314